The global avidin market size was valued at USD 287.50 million in 2025 and is projected to grow from USD 312.23 million in 2026 to USD 604.10 million by 2034, registering a CAGR of 8.60% during the forecast period (2026–2034). North America dominated the avidin market with a share of 52.4% in 2025.
Avidin is a naturally occurring protein found mainly in egg whites that binds strongly to biotin, a water-soluble B vitamin. It is widely used in biotechnology, diagnostics, and laboratory applications because of its strong and specific interaction with biotin. Avidin is tracked under HSN Code 3504 (peptones and other protein substances and their derivatives) and SIC Code 2836 (biological products, except diagnostic substances).
The avidin market demand is driven by its use in biotechnology research, diagnostic applications, and biochemical assays. The avidin market growth is led by demand for avidin-biotin binding systems in diagnostics, life science research, and biotechnology applications.
Regional Insights
Segment Insights
By Type
By Grade
By Application
By End User
Download a Free Sample To learn more about this report,
Broader Use of Avidin in Affinity Purification Workflows
The avidin market analysis shows broader use of avidin in affinity purification workflows. Its biotin affinity enables selective binding during protein purification and molecular biology procedures. This approach is supporting more specialized laboratory purification techniques.
Engineered Avidin Variants for Specialized Applications
The avidin market is moving toward engineered avidin variants with modified binding properties. These proteins can be tailored for specific avidin-biotin interactions in research and laboratory applications. This trend is creating specialized options for molecular biology, protein labeling, and biomolecule capture.
Supply chain disruptions are expected to have a moderate impact on the avidin market share, given its direct exposure to fluctuations in egg-derived raw materials, specialized extraction and purification materials, laboratory reagents, processing equipment, and transportation costs. The market is expected to have a U-shaped recovery as disruptions in raw material availability and specialized processing can create prolonged supply pressures before production capacity, inventories, and distribution conditions stabilize. The market is expected to grow at a CAGR of 8.60%, but supply chain constraints could approximately lower this by 1.5 percentage points, resulting in short-term growth of around 7.10%. As supply conditions normalize through improved raw material availability, stable processing capacity, and replenished inventories, avidin market growth is expected to gradually return to 8.60%.
In 2026, researchers at Universidad Nacional de Quilmes and CONICET received support under CONICET PIP 2021/23-1565, PIBBA 2022/23-0006, and Universidad Nacional de Quilmes PUNQ EBIODEM 1600/25 for research into recovering avidin from egg white using pseudo-affinity chromatography. The study directly concerns avidin extraction and processing.
Demand for High-Affinity Binding Reagents in Research and Use of Avidin in Immunoassay Development Drives Market
The demand for high-affinity binding reagents is driving the avidin market as research laboratories require highly specific molecular interactions for biomolecule capture, detection, labeling, and separation. The strong and selective avidin-biotin interaction supports its use across affinity-based research workflows, increasing demand for avidin-based reagents in biotechnology and life-science research.
The use of avidin in immunoassay development is driving the avidin market as researchers use avidin-based detection systems to identify biotinylated antibodies and other assay components with high specificity. Avidin-HRP reagents are used for detecting biotinylated antibodies in immunohistochemistry and other immunodetection workflows, supporting demand for avidin conjugates and related reagents.
Limited Raw Material Availability and Complex Purification Process Restrain Market Expansion
Avidin production depends mainly on suitable egg-derived raw materials, which can limit the availability of consistent feedstock. Variations in egg supply and raw material quality can affect production consistency and processing volumes. These limitations can restrict reliable supply and slow market expansion.
Complex purification processes are required to isolate avidin at the quality levels needed for research and biotechnology applications. Multiple processing and quality-control steps can increase production time and technical requirements. These factors can limit manufacturing scalability and restrict wider market adoption.
Agricultural Biotechnology and Food Processing Applications Open New Avenues for Avidin Market Players
Agricultural biotechnology companies can explore avidin for applications related to pest management and crop protection. Avidin can interfere with biotin availability in certain insects, creating scope for protein-based approaches to insect control. Biotechnology companies can develop avidin-related solutions for specialized agricultural applications.
Food processing offers another area for avidin-based product development. Avidin can be explored in applications involving egg proteins, ingredient processing, and functional food research. Food ingredient companies can investigate controlled uses of avidin to develop specialized products and processing solutions.
Application Standardization and Research Workflow Challenges Affect Avidin Market Growth
Differences in experimental protocols can make avidin performance difficult to compare across research and biotechnology applications. Variations in assay design, labeling methods, and binding conditions can create challenges for users when selecting and validating avidin-based products.
The integration of avidin into specialized diagnostic and biotechnological workflows can also require application-specific validation. Manufacturers may need to adapt product specifications and technical support to meet the requirements of different research, diagnostic, and life science applications.
The streptavidin segment accounted for a share of 42.6% in 2025, owing to its broad use in research, diagnostics, and biotechnology applications. Its strong binding properties support its leading position across these applications.
The recombinant avidin segment is expected to grow at a CAGR of 9.4% during the forecast period. Recombinant production enables consistent protein characteristics and supports its use in advanced research and biotechnology applications.
Request Customizationto receive a tailored report.
The research-grade segment accounted for a share of 45.3% in 2025, supported by its extensive use in laboratory research and protein binding studies. Its broad application across research settings supports its leading position.
The pharmaceutical grade segment is expected to grow at a CAGR of 9.7% during the forecast period. Growing use of high-purity avidin in pharmaceutical applications supports segment growth.
The diagnostics segment accounted for a share of 34.8% in 2025, owing to the use of avidin-based binding systems in diagnostic assays and detection methods. Its role in biomolecule detection supports widespread application.
The therapeutics and drug delivery segment is expected to grow at a CAGR of 10.1% during the forecast period. Avidin-based systems are being explored for targeted drug delivery and therapeutic applications.
The biotechnology and pharmaceutical companies segment accounted for a share of 36.5% in 2025, owing to their broad use of avidin in drug development, biotechnology research, and bioprocessing. Their involvement across multiple applications supports the segment's leading position.
The diagnostic laboratories segment is expected to grow at a CAGR of 8.7% during the forecast period. Wider use of avidin-based diagnostic methods supports adoption across diagnostic laboratories.
Speak to an Analystto discuss market opportunities.
North America: Market Dominance Led by High-Value Protein Research
The North America avidin market is expected to grow at a CAGR of 8.1% during the forecast period, making it the dominant regional market.
The U.S. avidin market is expanding through specialized protein-labeling workflows that use avidin to isolate and study biotinylated cellular components. Research laboratories are applying avidin-based capture systems to examine cell surface proteins and protein trafficking, creating recurring use of avidin reagents in advanced cell biology studies.
The Canada avidin market is developing through the use of avidin in targeted biomolecular labeling and purification workflows. Canadian research programs involving biotinylated proteins and engineered biomolecules are creating opportunities for higher-purity avidin reagents designed for specialized laboratory applications.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific: Fastest Growth Driven by Emerging Therapeutic Applications
The Asia Pacific avidin market is expected to grow at a CAGR of 10.4% during the forecast period, making it the fastest-growing regional market.
The Japan avidin market is advancing through research on engineered streptavidin platforms for targeted therapeutic delivery. Japan’s AMED-backed Research and Development Program for Innovative Biologics includes the engineered streptavidin-based system creating a potential pathway for specialized avidin-family products in drug delivery applications.
The China avidin market is expanding toward synthetic-cell and biomolecular engineering applications. A China-led initiative involving more than 100 laboratories across six Asian countries has established a 10 year roadmap for synthetic cell research, creating future opportunities for avidin family proteins.
The India avidin market is developing alongside advanced molecular diagnostic and antibody-engineering research. The expansion of indigenous antibody discovery and precision diagnostic programs is creating future applications for specialized avidin-based labeling and detection reagents in translational research.
Europe: Market Growth Supported by Diagnostic Assay Development
The Europe avidin market is expected to grow at a CAGR of 7.8% during the forecast period, supported by the increasing use of avidin and modified avidin reagents in immunoassays, protein labeling, and high-sensitivity laboratory detection.
The UK avidin market is benefiting from the development of advanced immunoassay and molecular detection workflows that require reliable avidin-based signal amplification. Avidin conjugated reagents are used to visualize biotinylated antibodies and other probes in ELISA, immunolabeling, and blotting applications, creating recurring requirements for specialized avidin conjugates.
The Germany avidin market is gaining applications in next-generation biosensor development, where avidin can function as a selective recognition component for biomolecule detection. Fraunhofer research has demonstrated avidin responsive polymer biosensors capable of detecting biomolecular interactions in real time, pointing toward future applications of avidin in high-throughput and sensor-based analytical platforms.
Latin America: Market Growth Supported by Advanced Molecular Research
The Latin America avidin market is expected to grow at a CAGR of 8.7% during the forecast period as research laboratories adopt more specialized reagents for sensitive biomolecule detection and assay development. In Brazil, FAPESP-supported research has explored avidin peroxidase detection with biotinylated aptamers for low-cost serological testing, creating a pathway for avidin-based reagents in accessible diagnostic assays. In Mexico, the National Institute of Genomic Medicine has expanded work combining artificial intelligence with advanced genomic technologies for undiagnosed rare diseases, creating opportunities for avidin-based detection components within emerging molecular research workflows.
Middle East & Africa : Market Growth Driven by Advanced Biomolecule Detection and Diagnostic Research
The Middle East & Africa avidin market is expected to grow at a CAGR of 7.5% during the forecast period, driven by the use of avidin-based affinity systems for selective biomolecule purification and high-sensitivity detection in research workflows. In the UAE, expanding molecular biology and analytical research capabilities are creating opportunities for avidin-based purification reagents. South Africa’s established research infrastructure supports applications involving protein isolation, immunoassays, and biomolecule analysis.
The avidin market competitive landscape is moderately consolidated, with established life science companies, biotechnology reagent manufacturers, research reagent suppliers, and specialized protein solution providers. Key players such as Thermo Fisher Scientific Inc., Merck KGaA, Vector Laboratories, Inc., Bio-Rad Laboratories, Inc., Promega Corporation, and New England Biolabs, Inc. are estimated to account for approximately 30–35% of the avidin market share.
Established players compete mainly through product quality, reagent purity, product variety, technical support, research capabilities, and global distribution networks. Emerging and regional players in the avidin market ecosystem focus on specialized avidin variants, customized protein solutions, cost-effective products, and application-specific reagents to strengthen their market presence.
May 2026: European patent EP4151278B1 was granted for a biotin-modified dimer and related applications. The patent specifically describes the use of avidin/streptavidin-biotin interactions in molecular biology, medicine and pre-targeted drug delivery.
May 2026: US patent application US20260139075A1 was published for a novel biotin-specific monoclonal antibody. The application defines avidin-type proteins to include avidin, neutravidin, streptavidin, bradavidin, traptavidin and engineered biotin-binding variants, highlighting continued development of the broader avidin-biotin platform.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Fetal Bovine Serum Market Size, Share, Growth, Analysis, 2034
Blood Culture Tests Market Size, Share, Growth, Analysis, 2034
CRISPR-Cas9 Gene Editing Technologies Market Size, Share, 2034
Centrifuge Market Size, Share, Growth, Analysis, Report, 2034
Cell Surface Markers Detection Market Size, Share, Growth, 2034
Paper Diagnostics Market Size, Share, Growth, Forecast, 2034
We are featured on:
sales@straitsresearch.com